The combination integration of diagnostic and therapeutic functionalities into one system generates theranostic platforms,which is quite appealing because of the potential for developing personalized nanomedicine[1-3].Herein,we report a new tumor-targetable theranostic agent based on core crosslinked (CCL) micelles,possessing tumor targetable moieties and fluorescence and magnetic resonance (MR) dual imaging modalities.